Hydroxyurea makes inflammation “just right”?

Slides:

Advertisements

Similar presentations

RNA interference in biology and disease by Carol A. Sledz, and Bryan R. G. Williams Blood Volume 106(3): August 1, 2005 ©2005 by American Society.

Advertisements

Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease by Marilyn J. Telen Blood Volume 127(7): February 18, 2016 ©2016 by.

Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.

Investigating a New Methodology for the Detection of Low Frequency 17p Deleted Clones in Chronic Lymphocytic Leukaemia (CLL): Impact on Prognostic Outcome.

Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation by Surbhi Shah, Faye L. Norby, Yvonne.

Why not the liver instead of the kidney?

Gene therapy: efficient targeting of hematopoietic stem cells

Uncontrolled Wnt signaling causes leukemia

The beauty of TLR agonists for CTCL

February 12 – 19, 2018.

GVHD-associated immunodeficiency: soil or seed?

MBL: mostly benign lymphocytes, but…

Platelets come back in from the cold

TCR-MHC-peptide(s): in vivo veritas

“Vitamin hypothesis”: explanation for allergy increase?

When IFN interferes with cell fate

Triple play of H pylori in ITP

Neonatal GATA1 mutant clones under the radar

Bulging glands? Blame it on B cells

Platelet Antibody Testing in Idiopathic Thrombocytopenic Purpura

Finding a diamond in the (mouse is) rough

It's all in the timing by Linda J. Bendall Blood

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

“Radical” model of thrombosis

by Zhenping Zhu Blood Volume 108(6): September 15, 2006

BTK inhibition in myeloma: targeting the seed and the soil

Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy by Chun.

Transplants for the elderly in myeloma

Nonmyeloablative conditioning for relapsed follicular lymphoma

V617F “JAKs” up myeloproliferative signal

FNAIT: the fetus pleads guilty!

T regulatory cells turn on T regulatory cells

Gnawing at Metchnikoff’s paradigm

Pregnancy outcomes after maternal exposure to rituximab

Fluorescent neutrophils throw the spotlight on inflammation

Deep mining of the RBC proteome

Acute promyelocytic leukemia, microgranular variant

by Lewis Hsu, Bhalchandra Diwan, Jerrold M. Ward, and Constance T

by Julia E. Geddings, and Nigel Mackman

Setting the table for macrophages

An actuarial GPS for hemophilic longevity

Taking a leaf from the book of oral tolerance

Has the T cell bitten off more than it can chew?

Basophils take a slice of IRF8 pie

by Sabah Sallah, and Jim Y. Wan

by Jayesh Mehta Blood Volume 112(2): July 15, 2008

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

Stage C or not stage C…? by Claire Dearden Blood

ROCK and Rho(ll) in bone marrow

Latest lymphoma classification is skin deep

HU for acute treatment of sickle VOC?

Gremlin: vexing VEGF receptor agonist

A new red cell shape helps the clot

Infected aneurysm of the thoracic aorta

by Fumiko Chino, Arif H. Kamal, Junzo Chino, and Thomas W. LeBlanc

Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective.

by Christine L. Kempton, and Amanda B. Payne

Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin by Sarah L. Reeves, Hannah K. Jary, Jennifer.

Overcoming “aspirin resistance” in MPN

Treatment versus Transplant for Challenging Hematologic Disorders

Anti-CD20-IL-21 fusokine: the tail wags the dog

How I treat disseminated intravascular coagulation

A binding relationship with thrombin

In Memoriam: E. Donnall Thomas

Hepatosplenic T-Cell Lymphoma: Clinicopathological Features and Treatment Outcomes: Report From The North American Peripheral T-Cell Lymphoma Consortium.

by Lucy A. Godley, and Akiko Shimamura

Initial treatment of CLL: integrating biology and functional status

Fire behind the fury: IL-18 and MAS

Hydroxyurea can eliminate transfusion requirements in children with severe β-thalassemia by Mohamed Bradai, Mohand Tayeb Abad, Serge Pissard, Fatima Lamraoui,

A schematic diagram showing the mechanism by which L5 triggers platelet activation and aggregation. A schematic diagram showing the mechanism by which.

Presentation transcript:

Hydroxyurea makes inflammation “just right”? by Lewis L. Hsu Blood Volume 119(8):1796-1798 February 23, 2012 ©2012 by American Society of Hematology

Baseline expression of E-selectin (represented by the frequency of “E” in each panel) affects the outcome of bacterial pneumonia challenge with Streptococcus pneumoniae. Baseline expression of E-selectin (represented by the frequency of “E” in each panel) affects the outcome of bacterial pneumonia challenge with Streptococcus pneumoniae. Professional illustration by Kenneth X. Probst. Lewis L. Hsu Blood 2012;119:1796-1798 ©2012 by American Society of Hematology